TP53 and neoplasm: In addition to breast MSCs, we found that TP53 and KMT2D were the most frequently mutated genes (6/6 and 4/6, respectively) in MSCs originating from the other three organs (esophagus, lung and kidney) (Figure 1); specifically, each tumor (n = 6) exhibited a TP53 mutation.